K. Hastings

Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia

E. Fikrig, Ryuta Uraki, H. Gaitsch, 2019, iScience.

Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo

D. Petrov, H. Wakelee, M. Diehn, 2020, bioRxiv.

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.

Guoping Cai, David L Rimm, Soldano Ferrone, 2017, Cancer discovery.

GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition

J. Blum, A. Haque, K. Hastings, 2022, International journal of molecular sciences.

Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

R. Herbst, D. Rimm, K. Politi, 2019, Clinical Cancer Research.

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

N. Schultz, M. Ladanyi, D. Zelterman, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells.

K. Politi, E. Felip, L. Paz-Ares, 2023, Cancer research.